Article
CDKN2 mutation is infrequent in german hepatocellular carcinoma.
Oncology - 1 Nov 1999
Volkmann M, Stilgenbauer F, Hofmann W J, Otto G, Schiff J H, Fiehn W
Abstract excerpt
For hepatocellular carcinoma, only scarce and controversial data on CDKN2 alterations are available. A high rate of mutations in a Chinese study contrasts with a low rate found in Japanese tumors and a CDKN2 germline mutation in 4/26 Swiss tumors examined. We analyzed 23 hepatocellular carcinomas from German patients for homozygous deletions of CDKN2 by coamplification with the human tyrosine hydroxylase (TH)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
